Adding Preoperative Radiotherapy Plus Cetuximab to Perioperative Chemotherapy for Resectable Esophageal Adenocarcinoma: A Single-Center Prospective Phase II Trial

BACKGROUND. Local and systemic recurrence are important sources of treatment failure following surgical resection of esophageal adenocarcinoma. We hypothesized that adding preoperative cetuximab and radiotherapy (cetux-RT) to perioperative chemotherapy would increase treatment efficacy with acceptab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ubink, Inge, van der Sluis, Pieter, Schipper, Marguerite, Reerink, Onne, Voest, Emile, Borel-Rinkes, Inne, Wijrdeman, Harm, Vleggaar, Frank, Agterof, Marriete, Overkleeft, Esther, Siersema, Peter, van Hillegersberg, Richard, Lolkema, M.P.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903062/
https://ncbi.nlm.nih.gov/pubmed/24335595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0254
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados